Price $1.27 |
Market Cap
21.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.26
|
P/S
-
|
Dividend %
-
|
|
P/CF
3.7
|
P/FCF
-
|
Op. Cash Flow
-3.8K
|
FCF
-0.4
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-523.80%
|
ROI
-554.70%
|
|
ROA
-264.80%
|
EPS Growth
26.10%
|
Current Ratio
2.7
|
Debt/Equity
71.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $21.15 | - | 4.80% | 17.38B | Strong Buy |
| Heat Biologics Inc (HTBX) | $2.06 | - | - | 6.3M | Strong Buy |
| Quorum Health Corp (QHC) | $4.27 | - | - | 238.9M | Strong Buy |
| Impax Laboratories Inc (IPXL) | $18.30 | - | - | 1.42B | Strong Buy |
| Senomyx Inc. (SNMX) | $1.36 | - | - | 56M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
